<< Read Full Article
<< Read Full Article
Cephalon Holders Take Flight
- Loading Comments...
Frank Baldino Jr.'s optimism aside, Cephalon's(CEPH Quote) shareholders weren't in a very forgiving mood Thursday.
Though the chairman and CEO of Cephalon says 2007 will be a "growth year" and that his company will enjoy "significant earnings growth in the next several years ahead," investors were concerned with a more immediate matter.
After the close of trading Wednesday, Cephalon said the Food and Drug Administration rejected its proposed treatment for attention deficit hyperactivity disorder, a drug called Sparlon. Cephalon said it will no longer seek approval for the drug. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,366.15 | 1,099.92 | 2,173.14 | 33.80 |
Oil *
77.73
|
|
DOWN
86.53
|
DOWN
9.32
|
DOWN
11.89
|
UP
0.57
|
10 Yr
3.38%
SPDR Gold
118.70
|
|
-0.83%
|
-0.84%
|
-0.54%
|
+1.72%
|
Data delayed 20 minutes |


Connect with TheStreet